The Nokia Rubber Workers' Sickness Fund (Nokian Kumiväen Sairauskassa) has entered into a partnership agreement with Finnish health technology company Koite Health Oy, deciding to increasingly focus on the oral health of its insured members. The fund will now reimburse the costs of Lumoral treatment for its insured members, providing a valuable additional benefit for maintaining oral health.

Lumoral is an innovative Finnish health technology solution that supports users' oral health by treating and preventing infections of the teeth and gums. The fund sees its solution as an important step towards preventive healthcare.

– The decision is based on thorough consideration and discussions with the fund's board. The board recognized the opportunities offered by the Lumoral device and unanimously decided to approve it as part of the benefits offered by the sickness fund, says Piia Virolainen, CEO of the Nokia Rubber Workers' Sickness Fund.

Piia Virolainen, CEO of the Nokia Rubber Workers' Sickness Fund.

Studies show that poor oral health is one of the major risk factors behind many common diseases, as inflamed gums and damaged tooth surfaces provide a direct route for bacteria.

– Oral infections are remarkably common globally, and they contribute to the onset of serious conditions such as cancer, diabetes, heart, lung, and kidney diseases, says Tommi Pätilä, a heart and organ transplant surgeon at HUS Children's Hospital, in Helsinki. Pätilä is also one of the developers of the Lumoral method.

– As the population ages, we are inevitably heading towards difficult times in healthcare and its financial management. Oral infections significantly increase the need for hospitalization and its complications. Therefore, investing in oral care and its comprehensive understanding – especially in the prevention of dental diseases – pays off multiple times in the future, Pätilä continues.

Oral diseases are a significant expense

According to Virolainen, the decision will practically mean that regular Lumoral treatment, including Lumorinse tablets, will be covered for the health fund's insured members as part of the fund's dental benefit.

– Regular Lumoral treatment has an impact on oral health, but it also affects the overall well-being of its users. The Nokia Rubber Workers' Sickness Fund is constantly striving to improve the well-being and health of its insured members. The reimbursement of Lumoral device and Lumorinse tablets is one step towards this goal, emphasizes Virolainen.

Virolainen states that the Nokia Rubber Workers' Sickness Fund reimburses the most research and treatment costs. The next highest reimbursement is for insured members' dental treatment costs.

– Dental diseases can lead to significant costs, making our fund's dental benefit a highly valued and frequently utilized resource among our insured members. Quick access to dental care, without the inconvenience of waiting, is considered essential by our insured members, Virolainen adds.

According to Lumoral Area Manager Riikka Nisula, local dental clinics have eagerly welcomed the decision of the Nokia Rubber Workers' Sickness Fund to reimburse Lumoral and Lumorinse tablets because prevention and enhancing self-care support professional treatment.

The antibacterial Lumoral treatment effectively removes harmful bacteria from the surfaces of the teeth and gum lines. Home-administered Lumoral treatment has been found to be significantly more effective and better tolerated than chlorhexidine-based mouthwashes, which are commonly used today.

Nisula emphasizes that the antibacterial treatment is carried out as an additional treatment to mechanical teeth cleaning and does not replace the need to brush teeth and clean between teeth. So why is additional treatment to enhance mechanical oral hygiene needed?

According to studies, brushing teeth removes only 65% of plaque. Residual plaque remains in the mouth after even the most effective teeth brushing. Lumoral helps to remove this residual plaque. With regular Lumoral treatment, the tooth surfaces are properly cleaned.

Antibacterial treatment has also been shown to prevent and treat infections of the tissues surrounding implants. The treatment is suitable for everyone, but light-activated antibacterial treatment is seen as most effective for patients who need enhanced oral hygiene.

The Nokia Rubber Workers' Sickness Fund is a so-called supplementary fund that reimburses insured members for additional benefits according to its rules. The fund has about 1,200 insured members. Altogether, there are about 110 health funds operating in Finland, whose insured members consist of employees and/or office personnel. In many funds, retirees can continue to be insured by the fund, and in some funds, family members are also entitled to reimbursements.

For more information:  

Sakari Nikinmaa
CEO, Koite Health
+358 40 8222 034, sakari@koitehealth.com

Piia Virolainen
CEO, Nokian Kumiväen Sairauskassa
+358 50577015,5 toimisto@nokiankumivaensairauskassa.fi

Periodontitis and diabetes are two prevalent diseases with a strong bidirectional relationship between them. Poorly managed diabetes promotes the progression of periodontitis and complicates its treatment. Conversely, active periodontitis adversely affects diabetes management and treatment.

In honor of World Health Day, Tommi Pätilä, a heart and transplant surgeon at HUS New Children's Hospital, in Finland, and Timo Sorsa, a professor of oral and maxillofacial diseases at the University of Helsinki, reflect on the connection between these two prevalent diseases from the perspective of oral health.

Diabetes and gum inflammation are two significant global health issues that require immediate attention. About half of the world's population suffers from gum inflammation, while nearly half a billion people have diabetes.

In Finland alone, there are approximately 500,000 diabetics, with about 50,000 suffering from type 1 diabetes and around 400,000 from type 2 diabetes. Additionally, it is estimated that there are up to 100,000 undiagnosed type 2 diabetics in Finland.

Understanding the Close Connection

Periodontitis is a disease of the tooth-supporting tissues that progresses from gum inflammation and can ultimately lead to tooth loss. Symptoms of the disease include red, swollen, and bleeding gums, gum recession, formation of gum pockets, loosening of teeth, bad breath, and possible swallowing and chewing problems.

Periodontitis is associated with many risk factors, such as smoking, genetic factors, and systemic diseases like diabetes.

The symptoms of the disease can vary from mild to severe and often require evaluation and treatment by a dentist or dental hygienist. Early detection and treatment are crucial for managing periodontitis.

Diabetic patients have an increased risk of developing periodontitis, and conversely, periodontitis has a negative impact on diabetes treatment and management. High blood sugar levels increase inflammation in the mouth and hinder the healing of periodontitis. The combined effect of these two diseases is also reflected in systemic inflammatory markers and blood sugar levels.

Traditional diagnostic methods are not always sufficient to identify the risk of periodontitis and diabetes. Therefore, new biomarker-based rapid tests have been developed to help identify the risk of these diseases at an early stage.

Oral Health Status Revealed in Minutes

The aMMP-8 rapid test developed in Finland is based on measuring the concentration of active matrix metalloproteinase 8 (aMMP-8) in mouthwash. Studies have shown that elevated levels of aMMP-8 may indicate both periodontitis and diabetes.

The aMMP-8 rapid test can be performed at the dentist's office, and the results are obtained immediately. This allows for early intervention in the development of periodontitis and assessment of the risk of diabetes. Additionally, the test provides patients with important information about their oral health and the risk of diabetes, which encourages better self-care and adherence to healthy lifestyles.

"The test allows for the detection of signs of periodontitis even before symptoms occur, which provides an opportunity for early treatment and prevention of complications," says Professor Timo Sorsa of the University of Helsinki's Department of Oral and Maxillofacial Diseases.

The test has proven to be useful in screening patients with type I, type II, and gestational diabetes.

Oral Health: A Crucial Factor for Diabetics

Diabetic patients with periodontitis require special attention, reminds pediatric heart and transplant surgeon Tommi Pätilä. Pätilä is also one of the developers of the Lumoral innovation, which enhances mechanical oral hygiene.

"It is especially important for diabetics to invest in regular oral hygiene and dental visits. This not only improves patients' quality of life but also reduces the risk of long-term complications," says Pätilä.

According to Pätilä, adjunctive therapies can be combined with at-home oral hygiene management, such as low-dose doxycycline acting as an aMMP-8 inhibitor and light-activated mouthwashes with anti-inflammatory effects.

"Antibacterial Lumoral treatment effectively removes harmful plaque bacteria from tooth surfaces and gum lines. Home-administered Lumoral treatment has been shown to be significantly more effective and better tolerated than chlorhexidine-based mouthwashes commonly used today," Pätilä explains.

Pätilä emphasizes that antibacterial treatment complements mechanical tooth cleaning and does not replace the need for brushing and cleaning between teeth. Why is additional treatment needed to enhance mechanical oral cleaning?

"Research shows that brushing only removes 65% of plaque. Residual plaque remains in the mouth even after the most effective brushing. Lumoral helps remove this residual plaque. Regular Lumoral treatment ensures that tooth surfaces are thoroughly clean. Diabetics, in particular, benefit from this removal of residual plaque," says Pätilä.

According to studies, regular adjunctive antibacterial treatment alongside traditional non-surgical standard treatment reduces inflammation in gum tissues and improves oral hygiene and healing of deep pockets in chronic periodontitis compared to conventional treatment.

Antibacterial treatment has also been shown to prevent and improve inflammation of peri-implant tissues. The treatment is suitable for everyone, but light-activated antibacterial treatment is seen as most effective for patients who require enhanced oral hygiene.

***

World Health Day, launched by the World Health Organization (WHO), is celebrated globally on April 7th to increase awareness of health issues. This year, the timely theme "My health, my right" emphasizes the importance of health equity.

*** 

References:

Trujillo K, Räisänen IT, Sorsa T, Pätilä T. Repeated daily use of dual-light antibacterial photodynamic therapy in periodontal disease—a case report. Dent J (Basel). 2022;10(9):163. doi:10.3390/dj10090163

Pakarinen S, Saarela RKT, Välimaa H, et al. Home-applied dual-light photodynamic therapy in the treatment of stable chronic periodontitis (HOPE-CP)—three-month interim results. Dent J (Basel). 2022;10(11):206. doi:10.3390/dj10110206

Gholami L, Shahabi S, Jazaeri M, Hadilou M, Fekrazad R. Clinical applications of antimicrobial photodynamic therapy in dentistry. Front Microbiol. 2023;13:1020995. doi:10.3389/fmicb.2022.1020995

Lähteenmäki H, Pätilä T, Räisänen I, Kankuri E, Tervahartiala T, Sorsa T. Repeated Home-Applied Dual-Light Antibacterial Photodynamic Therapy Can Reduce Plaque Burden, Inflammation, and aMMP-8 in Peri-Implant Disease – A Pilot Study. Curr Issues Mol Biol 2022; 44: 1273–1283. doi: 10.3390/cimb44030085

In the field of dental care, changes are constant as fresh ideas shape the industry. A recent collaboration agreement between Finland’s Koite Health Ltd and Trading Co., Ltd. from Thailand is set to revolutionize dental care standards by introducing innovative light-activated technology to the country.

Founded in 2017, Innodent has been at the forefront of delivering cutting-edge dental solutions to Thailand's healthcare sector. Driven by a commitment to leverage the latest advancements in high-tech solutions, the company aims to provide the most innovative technologies to the dental industry. This strategic vision led to a partnership with Koite Health, and the introduction of Lumoral, a Finnish med-tech innovation, to the dental market in Thailand.

– The introduction of Lumoral to Innodent's product portfolio was the result of a personal recommendation from Dr. Hildebrand, a renowned maxillofacial surgeon from Berlin. Dr. Hildebrand's successful clinical experiences with Lumoral convinced the team at Innodent to explore this revolutionary technology further, explains Thomas Constantin, CEO and owner of Innodent Trading Co., Ltd.

Lumoral: an innovative personal healthcare device

So, what exactly is Lumoral, and how does it work? Mr. Constantin reminds that the close link between oral bacteria and overall health and well-being is an important factor that sparked interest in the Finnish oral health-enhancing innovation in the first place.

– Oral bacteria can cause dental caries and bad breath but there can also be more severe secondary effects such as cardiovascular diseases, dementia, psoriasis and many more. Overall health starts with a healthy mouth. It is therefore important to regularly clean the mouth thoroughly.

Lumoral is an innovative personal healthcare device designed to remove 99.9% of harmful oral bacteria while preserving the healthy mouth flora. Traditional oral hygiene methods can only remove approximately 60% of bacteria, leaving behind a significant risk of oral health issues, Thomas explains.

Lumoral's advanced technology utilizes color molecules in its Lumorinse mouth rinse, which adhere to harmful oral bacteria attached to teeth surfaces and gum tissue in the mouth. Subsequently, the light emitted by the mouthpiece reacts with the green sensitizer, effectively breaking down the cell membrane of bacteria and destroying them both from inside and outside. This method ensures the eradication of harmful bacteria without the risk of resistance development.

Long-term benefits for implant patients

The addition of Lumoral to Innodent's product portfolio aligns with the company’s focus on dental implantology, with a specialization in ceramic implants. While the industry predominantly utilizes titanium implants, scientific evidence suggests a significant risk of peri-implantitis, an inflammation of the tissues surrounding these metal implants, over time.

– Lumoral presents a solution to mitigate this risk, offering long-term benefits for implant patients, Constantin says.

Furthermore, Lumoral's versatility extends beyond implant care, offering benefits for individuals with various oral health concerns, including chronic bad breath, gum disease, and orthodontic patients wearing braces or clear aligners.

– This accessibility makes Lumoral an invaluable addition to Innodent's offerings, catering to a diverse range of dental needs in Thailand.

– The great advantage of Lumoral however, is that everyone benefits from removing harmful oral bacteria. Whether you are wearing braces or clear aligners, suffer from chronic bad breath, gum disease or simply want to have a perfectly clean and healthy mouth, Lumoral is your solution.

Promising prospects for both companies

The collaboration between Koite Health and Innodent holds promising prospects for both companies and dental patients in Thailand. Mr. Constantin says that for Innodent, this partnership marks a significant expansion into the business-to-consumer (B2C) market, enabling the company to reach individual consumers through online channels like their dedicated webshop.

– This shift opens new avenues for marketing and sales, enhancing accessibility to innovative dental solutions for patients across the country. Ultimately, the collaboration aims to raise awareness about oral health and its crucial role in overall well-being among the Thai population.

– By introducing Lumoral's advanced technology to the market, Koite Health and Innodent are paving the way for a new era of dental care in Thailand, one that prioritizes prevention, innovation, and improved patient outcomes.